FDA Clearance Tracker · P040045-S127
VISTAKON® (senofilcon A) Brand Contact Lenses
Last checked: Nov 20, 2026Latest source record: Sep 22, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Sep 22, 2022
Approved
Time to decision
90 days
Received Jun 24, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040045-S127
- Device name
- VISTAKON® (senofilcon A) Brand Contact Lenses
- Applicant location
- Jacksonville, FL
- Received
- Jun 24, 2022
- Decided
- Sep 22, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040045
Device type
- Device type
- Lenses, soft contact, extended wear (LPM)
- Device class
- Class III
- Regulation
- 21 CFR 886.5925
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for a change to the material of the lens container closure (foil lidstock) for VISTAKON® (etafilcon A) and (senofilcon A) Brand Contact Lenses.
Source documents
Other decisions for Vistakon, Division of Johnson & Johnson Vision Car
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.